These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1700585)

  • 1. [Factors influencing prognosis of stage D2 prostatic cancer following endocrine therapy: comparison between short-term cancer death and long-term survival group].
    Masai M; Akimoto S; Isaka S; Shimazaki J; Yatani R
    Hinyokika Kiyo; 1990 Jun; 36(6):667-71. PubMed ID: 1700585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Retrospective clinical evaluation of prognosis factors in stage D2 prostatic cancer treated with endocrine therapy].
    Kudo K; Nagata M; Hayashi N; Imamura H; Kimura M; Mimura H; Matsuyama K; Shishido S; Chino I
    Hinyokika Kiyo; 1991 Feb; 37(2):129-34. PubMed ID: 1710871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Present status and questions on early prostatic cancer (stage A, B)].
    Oishi K; Arai Y; Takeuchi H; Yoshida O
    Hinyokika Kiyo; 1991 Aug; 37(8):789-93. PubMed ID: 1957722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical analysis of 169 patients with prostate cancer].
    Okaneya T; Mizusawa H; Yoneyama T; Taguchi I; Komiyama I; Kawakami M; Hosaka K; Tsuruta T; Murata Y; Komatsu H; Misawa K; Kiyokawa H
    Hinyokika Kiyo; 1996 Aug; 42(8):563-7. PubMed ID: 8889563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Progress of endocrine therapy for prostate cancer and results].
    Kanetake H
    Gan To Kagaku Ryoho; 1996 Mar; 23(4):413-7. PubMed ID: 8678491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in prostatic acid phosphatase, gamma-seminoprotein and prostate specific antigen after endocrine therapy for stage D2 prostate cancer].
    Akimoto S; Akakura K; Masai M; Isaka S; Shimazaki J
    Hinyokika Kiyo; 1990 Jul; 36(7):783-91. PubMed ID: 1700588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endocrine therapy of prostatic cancer].
    Shimazaki J; Fuse H; Zama S
    Gan No Rinsho; 1985 Jul; 31(9 Suppl):1195-201. PubMed ID: 4057576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of tegafur administration combined with hormonal therapy in patients with newly diagnosed stage D prostatic cancer].
    Kobayashi N; Yoshida K; Takahashi T; Saitoh H; Tari K; Satake I; Kojima S; Tsujii T; Negishi T; Horiuchi S
    Hinyokika Kiyo; 1990 Jul; 36(7):793-800. PubMed ID: 2239576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognosis of the patients with prostate cancer clinically confined within the pelvis].
    Akimoto S; Masai M; Isaka S; Shimazaki J; Murakami S; Igarashi T
    Hinyokika Kiyo; 1990 Sep; 36(9):1039-45. PubMed ID: 2239609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study on adenocarcinoma of the prostate].
    Yamamoto A; Yuasa M; Imagawa A; Kagawa S; Kurokawa K
    Hinyokika Kiyo; 1987 Dec; 33(12):2050-4. PubMed ID: 3448932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer.
    Labrie F; Dupont A; Giguère M; Borsanyi JP; Lacourciere Y; Bélanger A; Lachance R; Emond J; Monfette G
    Prog Clin Biol Res; 1988; 260():41-62. PubMed ID: 3283766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of chemohormonal therapy as an initial treatment for stage D2 prostatic cancer--effect of UFT administration combined with hormonal therapy].
    Honda M; Takasaki E; Suzuki T; Maeda S; Imai T; Hosoya Y; Chen JA
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):105-9. PubMed ID: 7826063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical studies on endocrine therapy of prostatic carcinoma (2): Prognosis of patients with prostatic carcinoma given endocrine therapy, and analyses of causes of death and side effects of endocrine therapy].
    Kumamoto Y; Tsukamoto T; Umehara T; Shimazaki J; Fuse H; Oshima H; Takeuchi H; Yoshida O; Okada K; Saito Y
    Hinyokika Kiyo; 1990 Mar; 36(3):285-93. PubMed ID: 2191570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.
    Jonsson E; Sigbjarnarson HP; Tomasson J; Benediktsdottir KR; Tryggvadottir L; Hrafnkelsson J; Olafsdottir EJ; Tulinius H; Jonasson JG
    Scand J Urol Nephrol; 2006; 40(4):265-71. PubMed ID: 16916765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study of prostatic cancer--statistical analysis of 184 cases in the latest 21 years].
    Yamashita A; Hayashi N; Sugimura Y; Yanagawa M; Arima K; Nakano S; Kimbara H; Tochigi H; Kawamura J
    Hinyokika Kiyo; 1995 Jun; 41(6):447-53. PubMed ID: 7645452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evolution and prognostic factors of adenocarcinomas of the prostate metastasizing at diagnosis].
    Arrizabalaga Moreno M; García González JI; Mora Durvan M; Díez Rodríguez JM; Esteban Artiaga R; Navarro Sebastián J; Castro Pita M; Paniagua Andrés P
    Actas Urol Esp; 1997 Sep; 21(8):724-36. PubMed ID: 9412221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined hormone-chemotherapy for stage D2 prostatic cancer: starting time of chemotherapy in relation to hormone therapy].
    Tsukamoto T; Fukui I; Kihara K; Goto S; Kitahara S; Kobayashi T; Kojima S; Oshima H
    Hinyokika Kiyo; 1996 May; 42(5):351-6. PubMed ID: 8752537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical studies on recurrent prostatic cancer].
    Suzuki K; Nakamura T; Kato N; Suzuki T; Imai K; Yamanaka H
    Hinyokika Kiyo; 1991 Jun; 37(6):595-600. PubMed ID: 1892007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hormonal treatment of carcinoma of the prostate].
    Obata K; Kobayashi H; Murase T; Ohisi M
    Hinyokika Kiyo; 1991 Aug; 37(8):809-16. PubMed ID: 1720272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation between re-biopsy one year after endocrine therapy and long-term prognosis in localized prostate cancer].
    Kameoka H; Katayose K; Kumakawa K; Shiraiwa Y; Uchida H; Takahashi Y; Yazaki J; Yamaguchi O
    Gan To Kagaku Ryoho; 2005 Jan; 32(1):57-63. PubMed ID: 15675583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.